33 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34067359 | DNMT3A Mutation-Induced CDK1 Overexpression Promotes Leukemogenesis by Modulating the Interaction between EZH2 and DNMT3A. | 2021 May 22 | 2 |
2 | 34233076 | Design, synthesis, and primary activity assays of baicalein derivatives as cyclin-dependent kinase 1 inhibitors. | 2021 Oct | 1 |
3 | 30250647 | Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response. | 2018 Aug 31 | 2 |
4 | 28176922 | Inhibition of Skp2 sensitizes lung cancer cells to paclitaxel. | 2017 | 1 |
5 | 27771926 | Potential Use of Flavopiridol in Treatment of Chronic Diseases. | 2016 | 1 |
6 | 23943501 | The Cdk inhibitor flavopiridol enhances temozolomide-induced cytotoxicity in human glioma cells. | 2013 Nov | 2 |
7 | 20419498 | Homology modeling, molecular dynamic simulation and docking studies of cyclin dependent kinase 1. | 2011 Feb | 4 |
8 | 21885916 | VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cells. | 2011 Nov 1 | 1 |
9 | 20206141 | Sequential treatment with flavopiridol synergistically enhances pyrrolo-1,5-benzoxazepine-induced apoptosis in human chronic myeloid leukaemia cells including those resistant to imatinib treatment. | 2010 Jul 1 | 2 |
10 | 21042745 | Novel microtubule-targeting agents, pyrrolo-1,5-benzoxazepines, induce cell cycle arrest and apoptosis in prostate cancer cells. | 2010 Dec | 1 |
11 | 17638911 | Histone deacetylase inhibitors enhance lexatumumab-induced apoptosis via a p21Cip1-dependent decrease in survivin levels. | 2007 Jul 15 | 1 |
12 | 14751090 | Small molecule inhibitors targeting cyclin-dependent kinases as anticancer agents. | 2004 Mar | 1 |
13 | 15023361 | Effects of pharmacological cyclin-dependent kinase inhibitors on viral transcription and replication. | 2004 Mar 11 | 1 |
14 | 15217973 | Preclinical and clinical development of the cyclin-dependent kinase inhibitor flavopiridol. | 2004 Jun 15 | 2 |
15 | 15308730 | Roscovitine inhibits activation of promoters in herpes simplex virus type 1 genomes independently of promoter-specific factors. | 2004 Sep | 2 |
16 | 15474478 | Molecular models of cyclin-dependent kinase 1 complexed with inhibitors. | 2004 Nov 12 | 6 |
17 | 12813134 | Flavopiridol enhances the effect of docetaxel in vitro and in vivo in human gastric cancer cells. | 2003 Jun | 1 |
18 | 14519054 | Clinical pharmacology of flavopiridol following a 72-hour continuous infusion. | 2003 Oct | 1 |
19 | 14562039 | Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-kappaB-dependent process. | 2003 Oct 16 | 1 |
20 | 11960485 | Structure-based design and synthesis of 2-benzylidene-benzofuran-3-ones as flavopiridol mimics. | 2002 Apr 25 | 2 |
21 | 12054639 | Structural basis for inhibition of cyclin-dependent kinase 9 by flavopiridol. | 2002 Apr 26 | 4 |
22 | 11464216 | The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in human leukemia cells (U937) through the mitochondrial rather than the receptor-mediated pathway. | 2001 Jul | 2 |
23 | 11063609 | Thio- and oxoflavopiridols, cyclin-dependent kinase 1-selective inhibitors: synthesis and biological effects. | 2000 Nov 2 | 3 |
24 | 11093360 | Flavopiridol, the first cyclin-dependent kinase inhibitor to enter the clinic: current status. | 2000 Dec | 1 |
25 | 10363974 | Discovery and initial characterization of the paullones, a novel class of small-molecule inhibitors of cyclin-dependent kinases. | 1999 Jun 1 | 2 |
26 | 10500810 | Synthetic cyclin dependent kinase inhibitors. New generation of potent anti-cancer drugs. | 1999 | 1 |
27 | 10665481 | Flavopiridol: the first cyclin-dependent kinase inhibitor in human clinical trials. | 1999 | 1 |
28 | 16127615 | Small molecule anticancer drugs. | 1999 Jun | 2 |
29 | 9427698 | Early induction of apoptosis in hematopoietic cell lines after exposure to flavopiridol. | 1998 Jan 15 | 2 |
30 | 9802881 | Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis. | 1998 Nov 1 | 2 |
31 | 8674031 | Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells. | 1996 Jul 1 | 1 |
32 | 8895733 | Flavopiridol: a cytotoxic flavone that induces cell death in noncycling A549 human lung carcinoma cells. | 1996 Nov 1 | 2 |
33 | 21541623 | Flavopiridol (L86 8275; NSC 649890), a new kinase inhibitor for tumor therapy. | 1996 Dec | 1 |